View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Theme
  2. Macro
  3. Covid-19
May 17, 2021

Coronavirus company news summary – Sputnik V vaccine launches in India – Sinopharm jab shows 78.89% efficacy in Phase III Middle East trial

By Chris Lo

Russia’s Sputnik V Covid-19 vaccine is now being used in India, as it becomes the first overseas-developed vaccine to be administered in the country. Sputnik V vaccine dosing was launched in Hyderabad from 14 May, after the first batch of the vaccine arrived on 1 May. The vaccine was approved under emergency use authorisation (EUA) in India on 12 April 2021.

An ongoing Phase III clinical trial of one of Sinopharm’s Covid-19 vaccines, being conducted in five Arab countries since 2020, has shown a 78.89% efficacy on people aged 18 years and above. According to Zhang Yuntao, vice president and chief scientist of Sinopharm China National Biotec Group, a subsidiary of Sinopharm, the trialled vaccine also demonstrated 100% protection against severe Covid-19 and hospitalisation resulting from the disease. Approximately 45,000 participants from 125 countries have been enrolled on the trials being conducted in Abu Dhabi, Bahrain, Egypt, Sharjah, and Jordan.

Ukraine’s Prime Minister Denys Shmyhal has announced that the country expects to receive a new shipment of 473,000 doses of Pfizer’s Covid-19 vaccine by late May this year, under the framework of the Covid-19 Vaccines Global Access (COVAX) facility. The new vaccine consignment is expected to be distributed among employees at Ukraine’s educational facilities.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology